semaglutide heart failure trial 📌 Most viewed this week from JAMA: In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for or all-cause mortality vs sitagliptin, but tirzepatide offered no Poll: Do you think we'll

Recommended articles A Systematic Review and Meta-Analysis of Efficacy and Safety of Liraglutide in Patients with Type 2 Diabetes Mellitus Joshi S, Das AK, Khunti K, Khunti S, Choudhari SY Diabetes, Metabolic Syndrome and Obesity 2026, 19:570273 Published Date: 8 March 2026

Injectable treatments will continue to play a huge role, particularly for people already established on treatment, people who prefer weekly dosing, and those using higher-dose options to maximise weight loss results

Researchers continue evaluating how these biological activities interact during controlled laboratory investigations

3 Taking lower doses can also help you adjust to changes in dosage

I think that theres still a lot more to be learned when it comes to these peptides and figuring out exactly what theyre doing, Dekker said.